- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Velcade
Total 591 results
-
M.D. Anderson Cancer CenterCompleted
-
European Myeloma NetworkJanssen, LPActive, not recruitingMultiple Myeloma | Extramedullary PlasmacytomaTurkey, Italy, Greece
-
NYU Langone HealthMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
University Medical Center GroningenCompleted
-
University of Colorado, DenverTerminatedRefractory Plasma Cell MyelomaUnited States
-
Second Affiliated Hospital of Soochow UniversityUnknownMyeloma | Dexamethasone | Granulocyte Colony-Stimulating Factor | Cyclophosphamide | BortezomibChina
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteJanssen Scientific Affairs, LLCActive, not recruitingMultiple MyelomaUnited States
-
University of ArkansasCompleted
-
Nanjing University School of MedicineCompleted
-
Clinical Service, China307 Hospital of PLA; Chinese PLA General Hospital; Peking University Third Hospital and other collaboratorsUnknownMultiple Myeloma | Plasma Cell LeukemiaChina
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); National Marrow Donor Program; Blood and Marrow...CompletedMultiple MyelomaUnited States
-
Emory UniversityMerck Sharp & Dohme LLC; Celgene CorporationCompleted
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
CelgeneMultiple Myeloma Research ConsortiumCompleted
-
University of CincinnatiMillennium Pharmaceuticals, Inc.Completed
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, France, Spain, Israel, India, Romania, Korea, Republic of, Singapore, Russian Federation, Poland
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaAustralia, Poland, United Kingdom, United States, Belgium, Germany, Spain, Argentina, Portugal, Bulgaria, Romania, Serbia, Turkey, Ukraine, Japan, Greece, Korea, Republic of, Brazil, Russian Federation, Hungary, Czechia, Croatia, Ge... and more
-
Paul Richardson, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsActive, not recruiting
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, United Kingdom, Italy, Israel, Portugal, Germany, Turkey, Greece, Ireland, Austria, Norway, Netherlands, Denmark, Poland, France, Russian Federation, Canada, Finland, Japan, Puerto Rico, Sweden
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia... and other conditionsUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Accelerated Community Oncology Research NetworkMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsCompleted
-
Sun Yat-sen UniversityRecruitingMyeloma | Newly Diagnosed | High RiskChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
Oncopeptides ABTerminatedMultiple MyelomaUnited States, France, Spain, Czechia
-
Duke UniversityMillennium Pharmaceuticals, Inc.TerminatedLymphoma, FollicularUnited States
-
Medical College of WisconsinRecruitingMultiple MyelomaUnited States
-
Yongping ZhaiUnknownMultiple MyelomaChina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Heart, Lung, and Blood Institute (NHLBI)TerminatedSickle Cell Anemia | Sickle Cell-hemoglobin C Disease | Sickle Cell-β0-thalassemiaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Millennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Oncology Specialists, S.C.Millennium Pharmaceuticals, Inc.TerminatedLymphoma, B-Cell | Lymphoma, Non-HodgkinUnited States
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Italy, Spain, France, Canada
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium Pharmaceuticals, Inc.CompletedRefractory Acute Leukemia | Relapsed Acute LeukemiaUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
PETHEMA FoundationCelgene; Janssen-Cilag Ltd.; TFS Trial Form SupportCompleted
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.; Janssen, LPCompleted
-
M.D. Anderson Cancer CenterJanssen Services, LLCCompleted
-
University of Colorado, DenverTerminatedPlasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell Myeloma | PlasmacytosisUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Xia ZhongjunAntengene CorporationRecruiting
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece